We use cookies and similar technologies that are necessary to operate the website. Additional cookies are used to perform analysis of website usage. By continuing to use our website, you consent to our use of cookies. For more information, please read our Cookies Policy.

Closing this modal default settings will be saved.

Vaccine Booster Shot For Immunocompromised Patients: FDA

Owner's Profile

Staff Writer, TLR

Published on July 14, 2023, 17:40:59


Vaccine, FDA

The FDA is expected to announce within the next 48 hours that it is authorizing Covid-19 booster shots for some people who are immunocompromised. This would be a third shot of the current two-dose Pfizer and Moderna vaccines. The CDC will meet on Friday to discuss booster doses of Covid 19 vaccines and additional doses for some. About 9 million Americans are estimated to be immunocompromised, either because of diseases they have or medications they take; and a third of eligible people in the US have not received even one dose of a Covid-19 vaccine. The Biden administration is expected to lay out a booster strategy for all vaccinated Americans in September.